Michael J Fusco
5PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 29, 2024
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.Michael J Fusco, Sandra J Casak, Sirisha L Mushti
|Dec 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco
|Dec 02, 2022
Highlights of FDA Oncology Approvals in 2022: Tissue-Agnostic Indications, Dosage Optimization, and Diversity in Drug Development.Elizabeth S Duke, Michael J Fusco, Patrick DeMoss
|Mar 19, 2022
Evaluation of Targeted Next-Generation Sequencing for the Management of Patients Diagnosed with a Cancer of Unknown Primary.Michael J Fusco, Todd C Knepper, Juliana Balliu
|Oct 08, 2021
Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas.Michael J Fusco, Yolanda Piña, Robert J Macaulay
Pageof 1
Frequent Collaborators
3 joint publications
Paul Kluetz
3 joint publications
Richard Pazdur
2 joint publications
Gulsum E Pamuk
2 joint publications
Lola A Fashoyin-Aje
2 joint publications
Bronwyn Mixter
2 joint publications
Kirsten B Goldberg
2 joint publications
Steven J Lemery
1 joint publications
Shenghui Tang
1 joint publications
Elizabeth S Duke
1 joint publications
Patrick DeMoss
